Omega Fund IV L.P. 13D and 13G filings for Replimune Group, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 08:35 am Sale |
2024-09-30 | 13G | Replimune Group, Inc. REPL |
Omega Fund IV L.P. | 2,709,991 4.000% |
-540,000 (-16.62%) |
Filing |
| 2024-02-14 4:44 pm Sale |
2023-12-31 | 13G | Replimune Group, Inc. REPL |
Omega Fund IV L.P. | 3,249,991 5.500% |
-360,487 (-9.98%) |
Filing |
| 2023-02-13 4:49 pm Sale |
2022-12-31 | 13G | Replimune Group, Inc. REPL |
Omega Fund IV L.P. | 3,610,478 7.200% |
-1,445,074 (-28.58%) |
Filing |
| 2022-02-14 3:18 pm Sale |
2021-12-31 | 13G | Replimune Group, Inc. REPL |
Omega Fund IV L.P. | 5,055,552 10.600% |
-274,231 (-5.15%) |
Filing |